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parameter has the potential to enhance non-invasive triage of patients for specific pulmonary vasodilator therapy.

Background
The management of pulmonary arterial hypertension (PHT) has been revolutionised over the last decade with the advent of specific pulmonary vasodilator therapies (1, 2) . These new drugs have delivered both symptomatic and prognostic benefit to patients with previously bleak outlooks. Echocardiography, with assessment of right ventricular function and estimation of right ventricular systolic pressure is the principle first-line clinical investigation and screening tool in these patients. However, even current guidelines(3), support invasive measurements of pressures and cardiac output obtained via right heart catheterisation (RHC) as the gold-standard for assessment of pulmonary artery pressure (PAP), pulmonary capillary wedge pressure (PCWP) as a surrogate for left atrial pressure (LAP), calculated trans-pulmonary gradient (TPG = PAP mean -PCWP), calculated diastolic pressure gradient (DPG = PAP diast -PCWP) and pulmonary vascular resistance (PVR = TPG/Cardiac Output) (4) .
For the purposes of triage and therapy selection, patients with pulmonary hypertension (invasive PAP mean >25mmHg(5)) are divided into two major physiologies (6) . Pre-capillary PHT patients are defined hemodynamically as having a PAP mean >25mmHg, with normal LAP (< 15mmHg). Typically these patients have intrinsic pulmonary vascular obstruction.
Arteriolar disease may be idiopathic (pulmonary arterial hypertension(6)), or related to connective tissue disorders (7, 8) ). Parenchymal lung diseases (6) such as idiopathic pulmonary fibrosis (9) and severe chronic obstructive pulmonary disease (10) , may cause secondary destruction of pulmonary capillary beds. Chronic thromboembolic pulmonary hypertension (CTEPH) will exhibit pre-capillary physiology with obstruction of small and medium-sized arteries. These patents, by definition, have normal left heart filling pressure (PCWP <15mmHg). Some of these patients may be candidates for specific therapies such as targeted pulmonary vasodilator therapy, anticoagulation or pulmonary thromboembolectomy (PTE) surgery.
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Numerically however, the commonest cause of PHT is left heart disease (6) . These postcapillary PHT patients are defined as having PAP mean >25mmHg with an elevated LAP (>15mmHg). This left atrial hypertension is usually secondary to left ventricular systolic and/or diastolic dysfunction from one or more of a variety of etiologies (such as hypertension, coronary artery disease, hypertrophic cardiomyopathy or valvular heart disease (11, 12) ). Resultant pulmonary venous congestion translates to elevated pulmonary artery pressures. These post-capillary cases are then divided into two groups. Isolated postcapillary PHT, with no secondary reactive pulmonary arteriolar disease, has a low DPG (<7mmHg) and PVR (<3WU). However with chronicity or intercurrent lung disease, many patients with elevated left atrial pressure develop secondary perivascular pulmonary arteriolar sclerosis resulting in increased DPG (>7mmHg) and/or PVR (<3WU) (13) . This phenomenon has variously been labelled "reactive" PHT, "out of proportion" PHT, or more recently "combined post-capillary and pre-capillary PHT"(3) (14) . These patients have typically hitherto not been candidates of specific pulmonary vasodilator therapy. More recently, some patients in this "out-of-proportion" combined pre-and post-capillary group have been treated with sildenafil, with some benefit (15) .
ePLAR -conceptualising a new parameter
There are echocardiographic surrogates for both elements of trans-pulmonary gradient - 
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obtained from the quotient of the peak transmitral pulsed-wave Doppler E-wave velocity divided by the mitral annular (septal or lateral) tissue Doppler tissue imaging E-prime (E:E') (20) . While there are a variety of confounders to this assessment (21) (22) (23) , the E:E' parameter has broadly been adopted by the echocardiography community as in indicator of normal versus elevated LAP (20, 24) .
The new parameter ePLAR, ePLAR (m/s) = TRV max(m/s) / mitral E:E'
is proposed as an echocardiographic surrogate for TPG and its interaction with LAP ( figure   1 ). This parameter utilises the TRV max (measured in metres/second), as a simplified indicator of pulmonary artery pressure and mitral E:E'(which is dimensionless) as a surrogate for LAP. The ePLAR is thus an "analogue" of the PAP/LAP gradient (TPG) and its units "metres/second" are conceptually appropriate as Doppler flow velocities are directly related to pressure gradients by the Bernoulli equation.
In pre-capillary PHT, the PAP (and TRV max ) will increase without significant elevations of LAP (and therefore E:E'). The ePLAR quotient will thus be expected to be higher than normal. In post capillary PHT, both the PAP (and TRV max ) and the LAP (and E:E') will increase. Numerically, the magnitude of the E:E' changes are an order of magnitude greater than any increase in TRV max . This will drive the ePLAR quotient lower than normal cases in post-capillary cases.
We hypothesised that ePLAR will differentiate pre-capillary pulmonary hypertension (elevated PAP mean with normal PCWP) from post-capillary pulmonary hypertension (elevated PAP mean and PCWP with or without elevated DPG) when compared to the gold standard of right heart catheterisation. We predicted that ePLAR will be higher in the pre-capillary PHT A C C E P T E D M A N U S C R I P T 
Methods
Patient Selection
Consecutive patients studied with right heart catheterisation, found to have PHT (PAP mean >25mmHg), who had complete echocardiographic data available, were studied. These patients were referred for investigation of dyspnoea. All had tricuspid regurgitation profiles 
Echocardiographic Methods.
Contemporaneous comprehensive transthoracic echocardiograms were performed with continuous wave Doppler assessment of tricuspid regurgitation peak velocity (TR V max ) and left heart trans-mitral pulsed-wave Doppler E-wave. Doppler tissue imaging peak e' velocities were obtained from the septal mitral annulus. Data from 3-5 beats was averaged in atrial fibrillation cases. Calculated ePLAR values from for all groups were summarised and compared.
As ePLAR is a hitherto uncharacterised parameter, reference population values for ePLAR, TRV max , and E/e' were obtained from a retrospective review of 16356 routine echocardiograms. Major pathology was excluded from this reference data set using these criteria left ventricular ejection fraction >=50%, TRV max <2/9m/s, left atrial area <22cm 2 , mitral E:E' <12, mean mitral gradient <5mmHg, peak trans-aortic velocity <2m/s, ventricular septal thickness < 12mm and moderate or less left heart valve regurgitation. The population was analysed with simple linear regression across decades.
Statistical Methodology:
Continuous variables were expressed as mean ± 1 standard deviation. Comparison between the continuous variables was performed using an unpaired t-test. Categorical variables were expressed as absolute values. The individual components of the ePLAR (TRV max , E-wave, E'
wave and E:E') were compared against their invasive counterparts by simple linear regression. Receiver operator characteristic testing was used to assess the discriminatory power of ePLAR (for pre-versus post-capillary) and all of its components. Sensitivity and specificity data generated optimal discriminatory cut-offs for ePLAR. A p value of <0.05 was
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considered as statistically significant. Statistical analysis was performed using Analyse-it® software (Leeds, United Kingdom).
Results
Patient Profile.
A group of 133 patients (66 male, average 65.0±16.5 years) with pulmonary hypertension (PAP mean > 25mmHg) on right heart catheterisation, with comprehensive transthoracic echocardiograms was studied. Of the Pre-capillary PHT cases (n=35, 26 male, 67+15 years), provisional diagnoses were idiopathic pulmonary arterial hypertension (43%), CTEPH (8%), Scleroderma / CREST / mixed connective tissue disease / lupus (20%) and pulmonary fibrosis/chronic obstructive airways disease (23%), bronchiectasis (3%) and bronchiolitis obliterans (3%). Post-capillary cases (n=98, 40 male, age 64+17 years) had preserved ejection fraction (HFpEF) in 62% and reduced left ventricular function in 32%.
The principle clinical diagnosis in 6% of these cases was idiopathic pulmonary arterial hypertension. The finding of elevated PCWP in such pulmonary patients raises issues about the strict applicability of these invasive criteria. 
Invasive Hemodynamics
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Echocardiographic data -ePLAR
The ePLAR was significantly higher in the pre-capillary PHT group than the total postcapillary group (0.44±0.22m/s vs 0.2±0.11m/s, p<0.001) (figure 2A figure 2B ).
Receiver operator characteristic analysis showed that ePLAR had a high discriminating power (AUC = 0.87, p<0.05) for distinguishing between pre-capillary and total post-capillary PHT groups. The components of the ePLAR (TRV max , transmitral pulsed wave Doppler Ewave, mitral annular E-prime and E:E') were also analysed against the RHC gold standard
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( figure 3A) . Each component showed weaker discriminatory power for pre-versus total post-capillary PHT than the composite ePLAR parameter (TRVmax AUC = 0.76, E-wave AUC = 0.75, E' AUC = 0.60, E:E' AUC = 0.796). Sensitivity analysis suggests a proposed optimal cut-off value for ePLAR of approximately 0.28m/s, with sensitivity and specificity of approximately 83% (see figure 3B) . Receiver operator characteristic analysis showed that ePLAR had a high discriminating power (AUC = 0.76) for differentiating pre-capillary PHT from combined pre-and post-capillary PHT (see figure 3C ) . Finally, receiver operator characteristic analysis showed that ePLAR had a modest discriminating power (AUC = 0.69)
for differentiating isolated post-capillary from pre-and post-capillary PHT (see Figure 3D ) .
Each of the elements of the ePLAR quotient was compared by linear regression with the relevant invasive parameter. There was modest correlation of TRVmax with PAPsys, E:E'
with PCWP and ePLAR with both TPG and DPG -see Figure 4 ).
Discussion
Differentiation of pre-capillary from post-capillary pulmonary hypertension has important clinical implications. Current specific vasodilator therapy is expensive, not without sideeffects, and appropriate for a very well characterised minority of patients with PHT(1, 2). As can be seen in our patient groups, only approximately one quarter of all patients undergoing RHC for investigation of elevated RVSP by echocardiography will have pre-capillary hypertensive physiology. Until now, this triage process has mandated invasive cardiac catheterisation (25) . A reliable and robust non-invasive differentiator of these physiologies could potentially reduce the number of costly, invasive, and potentially futile RHC procedures (26) . With the advent of specific pulmonary arterial hypertension units, an effective non-invasive screening tool offers the potential timely and appropriate referral of patients suitable for pulmonary vasodilator therapy and reduce the number of unnecessary referrals of patients with post-capillary physiology (27, 28) . In practical terms, elevated
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ePLAR values found in patients with elevated RVSP undergoing routine echocardiography should prompt the clinician to consider pre-capillary PHT conditions.
The fundamental tenet of the ePLAR is physiologically plausible. Pre-capillary PHT patients have elevated trans-pulmonary gradients levels, related to intrinsic pulmonary vascular obstructive disease (perivascular fibrosis in pulmonary arterial hypertension(5) or scleroderma (7, 29) ) and/or intrinsic parenchymal lung conditions (such as idiopathic pulmonary fibrosis(9, 30) or emphysema(10, 31)) which destroy vascular beds. Right ventricular afterload is elevated and trans-pulmonary pressure transmission to the left atrium is impaired. It follows that LAP will be low-normal in these patients, in the absence of left heart disease. The more severe the pulmonary vascular obstructive disease, the wider the gap between PAP and LAP (i.e. increased TPG). It was hypothesised that this same trend would paralleled in the non-invasive parameter, ePLAR. The data from this foundation study supports this prediction.
The corollary should be true in post-capillary PHT. Whilst TRV max will rise above normal (e.g. from approx. 2.3m/s to 3.3m/s), the E:E' in patients with clinically significant left atrial hypertension (LAP>15mmHg) will rise numerically much more (e.g. from E:E' = 8.3 to E:E' = 21.6). The quotient ePLAR will progressively fall as the LAP (and therefore E:E') rises.
More severe the left atrial hypertension yields lower the ePLAR values.
In this foundation group, there was a very clear dichotomy of the ePLAR in the pre-capillary PHT cases (which were significantly higher than normals) and the post-capillary PHT cases (which were significantly lower than normals). Receiver operator analysis showed a powerful differentiating ability of the ePLAR against the invasive RHC gold standard.
Importantly, the ePLAR had a greater discriminating power than any of its components. This also is biologically plausible. The ePLAR has the advantage of deriving Doppler parameters from both sides of the heart. Conceivably, the same confounders of the Doppler determinations of PAP and LAP, may "cancel out" by this numeric division in each patient.
This internal consistency and the numerical divergence of the factors of the equation, probably both contribute to the differentiating power of the ePLAR.
In this data set, as in most published series, Doppler predications of PAP (such as RVSP via TRV max (29) , PAP mean via pulmonary acceleration time (32) (16) and issues related to the accurate echocardiographic measurement of the TRV max .
Differentiating those patients with isolated post-capillary PHT from the combined pre-and post-capillary PHT groups is of some clinical significance. In some countries, use of the pulmonary vasodilator sildenafil, has been employed in this group of patients with reactive pulmonary vascular obstruction in the setting of left heart disease with some benefit (15).
This more subtle determination was evident in this study. The ePLAR parameter did increase in post-capillary patients as the DPG rose "out-of-proportion" in the combined preand post-capillary group, becoming statistically similar to age-related normal values. As all patients in this study had PHT, the finding of a "normal" ePLAR implies rising TPG in patients with elevated E/e'.
The reference 16356 "normal" population data reviewed for this study shows a trend towards slightly lower mean ePLAR values with increasing age. This needs to be taken into account when considering the ePLAR in a given patient. Specifically, in the older patient, the threshold to consider that pre-capillary physiology is present may be slightly lower. Clinically, it desirable to have a slightly higher sensitivity so as to minimise the false negative rate (patients who may be "ruled out" as potential candidates for specific pulmonary vasodilator therapy by this non-invasive screening test.
ePLAR is a an echocardiographic parameter that could be applied to routine 
Limitations
The main limitation of this study is the non-simultaneous collection of the echocardiographic and invasive RHC data. This allows for the confounder of changed in loading conditions. In pre-capillary patients, variation in filling status will be expected to have very little effect on hemodynamics with fixed elevations of TPG being the main physiologic determinant. The ePLAR in this group would not be expected to be significantly affected by changes in filling A C C E P T E D M A N U S C R I P T
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status. In post-capillary (left heart driven) cases, changes in filling may be reflected as changes in E:E'. Specifically, diuretic therapy will lower the E/e' (and probably the TRV max )
with associated increases in the ePLAR. The E/e' parameter has its own limitations. It is less reliable in special diseases, e. g. in healthy persons or hypertrophic cardiomyopathy etc.
In the specific situation of pericardial constriction, the E/e' value is low, but the filling pressure is very high. Further, a sub-group of patients with pulmonary hypertension do not have a measurable spectral Doppler tricuspid regurgitant jet. As such, the ePLAR cannot be calculated in these individuals.
Conclusions
Pulmonary hypertension is a common condition with a heterogeneous range of aetiologies. 
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